Exploring the pathophysiology underlying clozapine‐induced enhancement of glutamatergic transmission through L‐glutamate and D‐serine release associated with pannexin1 hemichannels
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Motohiro Okada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu, Japan. Hauptthemen laut MEDLINE: Connexins, Clozapine, Serine, Nerve Tissue Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background and purpose Clozapine, an approved antipsychotic for treatment‐resistant schizophrenia (TRS), enhances glutamatergic transmission by increasing exocytosis and non‐exocytosis glutamate release; however, its full action remained to be clarified. Experimental approach This study determined the effects of chronic administration of clozapine on tripartite‐synaptic glutamatergic transmission associated with N‐methyl‐D‐aspartate (NMDA)/glutamate receptors (NMDARs) by using microdialysis, cultured astrocytes and capillary immunoblotting. Key results Chronic clozapine administration dose‐ and time‐dependently increased the basal release of L‐glutamate and D‐serine from astrocytes in the prefrontal cortex. A therapeutically relevant concentration of clozapine increased the expression of phosphorylated‐Src, but not pannexin1, whereas a supratherapeutic concentration of clozapine increased the expression of both pannexin1 and phosphorylated‐Src. Clozapine‐induced increase of L‐glutamate and D‐serine release was inhibited by inhibitors of Src kinase and pannexin1 hemichannels, but not by inhibitors of NMDAR and connexin43‐hemichannels. Clozapine enhanced synthesis of L‐β‐aminoisobutyrate (L‐BAIBA) also increased astroglial release of L‐glutamate and D‐serine through pannexin1 hemichannels and increased expression of pannexin1 and phosphorylated Src. Activation of pannexin1‐hemichannels by chronic administration of clozapine and L‐BAIBA was regulated by Src kinase, which was inhibited by an inhibitor of group‐III metabotropic glutamate receptors (III‐mGluR). L‐BAIBA enhances III‐mGluR, although clozapine did not directly affect III‐mGluR activity. Conclusions and implications Enhanced glutamatergic transmission by chronic administration of therapeutically relevant concentrations of clozapine involves increased L‐BAIBA signalling, which activates Src signalling via III‐mGluR agonistic action, without affecting pannexin1 expression. Activation of pannexin1‐hemichannel activity induced by Src signalling and III‐mGluR may play an important role in the effectiveness of clozapine in TRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu, Japan.
ORCID-Profile: Motohiro Okada, Ruri Okubo, Eishi Motomura
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Okada, M., Okubo, R., & Motomura, E. (2025). Exploring the pathophysiology underlying clozapine‐induced enhancement of glutamatergic transmission through L‐glutamate and D‐serine release associated with pannexin1 hemichannels. British Journal of Pharmacology. https://doi.org/10.1111/bph.70112
Vancouver
Okada M, Okubo R, Motomura E. Exploring the pathophysiology underlying clozapine‐induced enhancement of glutamatergic transmission through L‐glutamate and D‐serine release associated with pannexin1 hemichannels. British Journal of Pharmacology. 2025. doi:10.1111/bph.70112
BibTeX
@article{Okada2025,
author = {Okada, Motohiro and Okubo, Ruri and Motomura, Eishi},
title = {Exploring the pathophysiology underlying clozapine‐induced enhancement of glutamatergic transmission through L‐glutamate and D‐serine release associated with pannexin1 hemichannels},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70112}
}
EUVIMED